Fascinating that suddenly we have new-identity posters (who sound remarkably like other-identity posters on other websites) and the return of an old basher, and a full-court press of FUD on other websites, making false claims, trying to scare new readers/shareholders, etc.
Those of us who are familiar with this stock and its history are not going to be frightened into selling. I hope that any newer shareholders will go to www.cellceutix.com and also will read the stickies on this page so that they are not alarmed by FUD being posted.
The fact is: CTIX was the victim of an utterly inaccurate and demonstrably false and malicious article on Seeking Alpha, written by an avowed short-seller. This triggered a huge move down in the stock, which was aided by an interestingly timed claim of a shareholder suit (dismissed by the judge) made by a law firm whose business consists of such lawsuits. Now we see a frantic effort by some posters to claim that all of the price suppression of this stock is the result of Aruda selling a couple million shares, which was about 20-25% of the Aruda family's large position in the stock. In my opinion that was a logical diversification that any financially responsible individual would certainly consider, based on whatever their personal financial situation was.
Anyone who has watched the stock trading during the day has seen many days in which the stock price was up all day, and then at the close a "trade" of as little as 10 shares knocked the price down. There have been many instances that many of us have remarked upon, in which a huge "offer" of shares suppressed price -- until someone came in with an actual offer, at which point the giant offer was withdrawn, the person bought at a higher price, and then the giant offer at a lower price came back in. No one can say that this is normal trading.
Nor is it true that the low price -- approximately 150 million market cap for a company with 3 different drugs in 5 clinical trials for different applications -- is fair pricing. It isn't. It's absurd, and the FUD attempting to scare people out of their stock and to scare away new buyers tells us one thing: it is very much in someone's financial interest to keep this stock price low.
This is not the fault of the company or its management. It's not the fault of Aruda for selling some of his (in my opinion undeserved) gains. It is the fault of the short seller who fomented the attack on share price, and of the law firm that publicized the completely discredited "shareholder" suit, and of the traders' gangs and market makers and hedge funds that are continuing to try to hold the price down. These activities will fail utterly when the clinical trials move further along and the value of CTIX's drugs begins to be recognized.
That time will be very soon.
Those of us who are familiar with this stock and its history are not going to be frightened into selling. I hope that any newer shareholders will go to www.cellceutix.com and also will read the stickies on this page so that they are not alarmed by FUD being posted.
The fact is: CTIX was the victim of an utterly inaccurate and demonstrably false and malicious article on Seeking Alpha, written by an avowed short-seller. This triggered a huge move down in the stock, which was aided by an interestingly timed claim of a shareholder suit (dismissed by the judge) made by a law firm whose business consists of such lawsuits. Now we see a frantic effort by some posters to claim that all of the price suppression of this stock is the result of Aruda selling a couple million shares, which was about 20-25% of the Aruda family's large position in the stock. In my opinion that was a logical diversification that any financially responsible individual would certainly consider, based on whatever their personal financial situation was.
Anyone who has watched the stock trading during the day has seen many days in which the stock price was up all day, and then at the close a "trade" of as little as 10 shares knocked the price down. There have been many instances that many of us have remarked upon, in which a huge "offer" of shares suppressed price -- until someone came in with an actual offer, at which point the giant offer was withdrawn, the person bought at a higher price, and then the giant offer at a lower price came back in. No one can say that this is normal trading.
Nor is it true that the low price -- approximately 150 million market cap for a company with 3 different drugs in 5 clinical trials for different applications -- is fair pricing. It isn't. It's absurd, and the FUD attempting to scare people out of their stock and to scare away new buyers tells us one thing: it is very much in someone's financial interest to keep this stock price low.
This is not the fault of the company or its management. It's not the fault of Aruda for selling some of his (in my opinion undeserved) gains. It is the fault of the short seller who fomented the attack on share price, and of the law firm that publicized the completely discredited "shareholder" suit, and of the traders' gangs and market makers and hedge funds that are continuing to try to hold the price down. These activities will fail utterly when the clinical trials move further along and the value of CTIX's drugs begins to be recognized.
That time will be very soon.
7
